OpGen Announces Results of Special Meeting of Stockholders
ROCKVILLE, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power...
Source: globenewswire.com
Page 21 - Opgen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Opgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Opgen Today - Breaking & Trending Today
OpGen Appoints Albert Weber as Chief Financial Officer
Albert Weber to join OpGen as OpGen’s CFO effective January 1, 2022 from U.S.-German molecular diagnostics company EpigenomicsAnnounces inducement grant of...
Source: globenewswire.com
OpGen Receives FDA Clearance for Acuitas® AMR Gene Panel
OpGen’s Acuitas® AMR Gene Panel allows testing for a comprehensive panel of 28 genetic AMR markers in isolated bacterial colonies from 26 different...
Source: globenewswire.com
OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webinars
ROCKVILLE, Md., June 09, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, today announced that its subsidiary Ares Genetics, which strives to become a leader in bacterial genomics and the AI-powered prediction of antimicrobial resistance (AMR), is developing a culture-free, genomic assay for comprehensive AMR surveillance. Dr. Johannes Weinberger, NGS Laborat
Source: yahoo.com
OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients
Experts presented the results of their Unyvero studies and demonstrated: Distinguishing those COVID-19 ICU patients with bacterial superinfection early and accurately is crucial for patient management and antibiotic stewardshipUnyvero detected bacterial pathogens up to 7 days earlier and would have enabled prompt and appropriate targeted antibiotics in 41.3% of cases and reduced time to appropriate therapy by 25.7 hours GAITHERSBURG, Md., April 12, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnost...
Source: yahoo.com